netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB researchers honored with 2018 António Champalimaud Vision Award

Prestigious award is for the scientists’ work, which led to the first gene therapy for an inherited disease.

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research, which collectively led to the development and 2017 FDA approval of Luxturnaä, a successful treatment for a type of Leber congenital amaurosis (LCA).  LCA is a genetic cause of childhood blindness.  Their work also demonstrated the potential for future developments in gene therapy for other inherited diseases, and led to the first gene therapy for an inherited human disease.  The RPB-associated awardees include: 

  • Jean Bennett, MD PhD, FARVO, of the University of Pennsylvania School of Medicine. Bennett is the recipient of multiple awards from RPB, including a Career Development Award (1992), Special Scholar Award (2000), Lew R. Wasserman Merit Award (2004) and Senior Scientific Investigator Award (2007).
  • Albert Maguire, MD, of the Children's Hospital of Philadelphia, who received RPB’s Physician-Scientist Award in 2001.
  • Samuel Jacobson, MD, PhD, of the Scheie Eye Institute, University of Pennsylvania School of Medicine, 2000 recipient of the RPB Senior Scientific Investigator Award.
  • William Hauswirth, PhD, of the University of Florida College of Medicine, who received the Senior Scientific Investigator Award in 1997.
  • Robin Ali, PhD, FMedSci, of the Institute of Ophthalmology of the University College of London. Ali has been a member of the RPB Scientific Advisory Panel since 2015.

The five – and two others who will receive the Champalimaud Award – will share a 1 million Euro prize.  The awardees will also present a special lecture at ARVO 2019 in Vancouver.

The António Champalimaud Vision Award is supported by Vision 2020 - The Right to Sight, a global blindness-prevention initiative launched in collaboration with the World Health Organization and the International Agency for the Prevention of Blindness.

 lEARN MORE ABOUT THE AWARD

 

Related News: Feature Story, For the Media, Gene Therapy, Top Story

RPB logo

Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants

RPB launches awards in data science and Diabetic Eye Disease.

Read More

 
RPB Logo

Vision Research Funding Partnership Event Takes Place Today

Leaders of organizations that fund vision research convene in Washington DC to increase collaboration and maximize the impact of research funding for sight-threatening diseases.

Read More

 
Dr. Raj Apte

Understanding Corneal Injuries in Dry Eyes

An RPB grantee makes a key discovery involving genes that are essential for eye health.

Read More

 
RPB logo

Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research

RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.

Read More

 
Giving Tuesday logo

RPB Supporters Save Sight on Giving Tuesday

We welcome your generosity to help us meet our goal!

Read More

 
Dr. Palczewski and lab members

An RPB Awardee Tackles Inherited Retinal Diseases

Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.